Based on the results of subsequent prognostic analysis, we selected B7-H4, CD3, CD8, CD20, and CD68 for multiplex immunofluorescence staining to show more straightforwardly the differences in the tumor immune microenvironment of the primary tumor and brain metastases. The gene discussed is VTCN1; the disease is neoplasm.